Person profile
Public information reviewedSandesh Mahatme, LL.M.
Board role
Director · CRISPR Therapeutics AG (NASDAQ: CRSP)
CRISPR Therapeutics AG (NASDAQ: CRSP)
Director · Current mandate
Director · Executive
- Public sources
- 3 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- May 6, 2026

